Lenacapavir described as ‘next best thing’ to an HIV vaccine will cost $40 a year for each patient in 120 countries from 2027, funders say
Cheap supplies of a groundbreaking twice-yearly HIV preventio…
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Lenacapavir
since
auto-detected in 3 stories
5 months ago
8 months ago
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers ○
As regulator prepares to approve lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’
A drug with the potential to “end the…
11 months ago
Annual jab for HIV protection passes trial hurdle ○
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
page 1 of 1